Pharmasset, Inc. Company Profile
We are a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Our primary focus is on the development of oral therapeutics for the treatment of human immunodeficiency virus, or HIV, hepatitis B virus, or HBV, and hepatitis C virus, or HCV. Our research and development efforts focus on a class of compounds known as nucleoside analogs, which act to inhibit the natural enzymes required for viral replication.
303-A College Road East
United States of America
Phone: (609) 613-4100
Fax: (609) 613-4150
I think it is important to also point out that it cost Gilead $11 billion to acquire Pharmasset and thereby secure the rights to Sovaldi. They still had to pay costs associated with completing develo...
The ruling, announced by Idenix January 29, is the latest setback for Idenix, which is trying to prove that its patents were violated by the biotech company Pharmasset (now part of Gilead). In the lat...
Gilead's hepatitis C drug, Solvaldi, sales have really taken off. Analysts are predicting megablockbuster status -- with high predictions of as much as $8 B in annual sales by as early as this year. T...
Idenix Pharmaceuticals has announced that the US Patent and Trademark Office (USPTO) Patent Trial and Appeal Board issued a decision in the first patent interference proceeding (No. 105,871) concernin...
ByGaurav S. Sharma:Gilead Sciences (GILD) has been a tremendous performer over the last few years as part of the multi-year biotech bull market. However, it has taken a significant dip in the past few...
ByPharma Reports:Last week, the FDA approved Gilead Sciences' (GILD) Sovaldi for hepatitis C. The approval was very much anticipated, nevertheless, since we have developed a deep interest in tracking...
Gilead is not the original developer of Sovaldi, its new Hepatitis C medication that will cost $84,000 for a 12-week course of treatment; instead, it bought the drug developer, ri...
Drugs and Medications
We are a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Our primary focus is on the development of oral therapeut...
More Information about "Pharmasset, Inc." on BioPortfolio
We have published hundreds of Pharmasset, Inc. news stories on BioPortfolio along with dozens of Pharmasset, Inc. Clinical Trials and PubMed Articles about Pharmasset, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmasset, Inc. Companies in our database. You can also find out about relevant Pharmasset, Inc. Drugs and Medications on this site too.